Nano Retina Inc.
Artificial retina for degenerative ophthalmic diseases
This article was originally published in Start Up
Executive Summary
Israel’s Nano Retina Inc. is developing an artificial retina that it hopes will provide a superior solution for restoring sight to patients with late-stage AMD and other degenerative ophthalmic diseases, who currently have no curative options. Its permanently implantable device is powered by an eye-safe laser that can be imbedded or attached to eyeglasses.